Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
Konukiewitz B, Kasajima A, Schmitt M, Schwamborn K, Groll T, Schicktanz F, Delbridge C, Schütze LM, Wilhelm D, Lang C, Lange S, Foersch S, Jank P, Steiger K, Werder AV, Denkert C, Weichert W, Klöppel G, Jesinghaus M. Konukiewitz B, et al. Among authors: denkert c. Cancers (Basel). 2021 Oct 12;13(20):5111. doi: 10.3390/cancers13205111. Cancers (Basel). 2021. PMID: 34680258 Free PMC article.
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups.
Schmitt M, Silva M, Konukiewitz B, Lang C, Steiger K, Halfter K, Engel J, Jank P, Pfarr N, Wilhelm D, Foersch S, Denkert C, Tschurtschenthaler M, Weichert W, Jesinghaus M. Schmitt M, et al. Among authors: denkert c. Cancers (Basel). 2021 Dec 7;13(24):6177. doi: 10.3390/cancers13246177. Cancers (Basel). 2021. PMID: 34944797 Free PMC article.
Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma.
Jesinghaus M, Herz AL, Kohlruss M, Silva M, Grass A, Lange S, Novotny A, Ott K, Schmidt T, Gaida M, Hapfelmeier A, Denkert C, Weichert W, Keller G. Jesinghaus M, et al. Among authors: denkert c. J Pathol Clin Res. 2022 Sep;8(5):448-457. doi: 10.1002/cjp2.284. Epub 2022 Jun 17. J Pathol Clin Res. 2022. PMID: 35715937 Free PMC article.
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification.
Foersch S, Lang-Schwarz C, Eckstein M, Geppert C, Schmitt M, Konukiewitz B, Groll T, Schicktanz F, Engel J, Gleitsmann M, Westhoff CC, Frickel N, Litmeyer AS, Grass A, Jank P, Lange S, Tschurtschenthaler M, Wilhelm D, Roth W, Vieth M, Denkert C, Nagtegaal I, Weichert W, Jesinghaus M. Foersch S, et al. Among authors: denkert c. Br J Cancer. 2022 Oct;127(7):1270-1278. doi: 10.1038/s41416-022-01889-1. Epub 2022 Jul 21. Br J Cancer. 2022. PMID: 35864156 Free PMC article.
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading.
Jesinghaus M, Boxberg M, Schmitt M, Kriegsmann M, Harms A, Lang C, Muley T, Winter H, Kriegsmann K, Warth A, Stenzinger A, Denkert C, Hoffmann H, Safi S, Weichert W. Jesinghaus M, et al. Among authors: denkert c. J Pathol Clin Res. 2022 Nov;8(6):567-578. doi: 10.1002/cjp2.295. Epub 2022 Sep 16. J Pathol Clin Res. 2022. PMID: 36111649 Free PMC article.
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board.
Tarawneh TS, Rodepeter FR, Teply-Szymanski J, Ross P, Koch V, Thölken C, Schäfer JA, Gremke N, Mack HID, Gold J, Riera-Knorrenschild J, Wilhelm C, Rinke A, Middeke M, Klemmer A, Romey M, Hattesohl A, Jesinghaus M, Görg C, Figiel J, Chung HR, Wündisch T, Neubauer A, Denkert C, Mack EKM. Tarawneh TS, et al. Among authors: denkert c. Cancers (Basel). 2022 Sep 12;14(18):4430. doi: 10.3390/cancers14184430. Cancers (Basel). 2022. PMID: 36139590 Free PMC article.
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling.
Denkert C, Romey M, Swedlund B, Hattesohl A, Teply-Szymanski J, Kommoss S, Kaiser K, Staebler A, du Bois A, Grass A, Knappmeyer C, Heitz F, Solimeno C, Ebel T, Harter P, Marmé F, Jank P, Gaiser T, Neff C, Wagner U, Timms KM, Rodepeter F. Denkert C, et al. J Mol Diagn. 2022 Dec;24(12):1254-1263. doi: 10.1016/j.jmoldx.2022.09.004. Epub 2022 Sep 30. J Mol Diagn. 2022. PMID: 36191839 Free article.
Increased Density of Growth Differentiation Factor-15+ Immunoreactive M1/M2 Macrophages in Prostate Cancer of Different Gleason Scores Compared with Benign Prostate Hyperplasia.
Bonaterra GA, Schleper A, Skowronek M, Kilian LS, Rink T, Schwarzbach H, Heers H, Hänze J, Rexin P, Ramaswamy A, Denkert C, Wilhelm B, Hegele A, Hofmann R, Weihe E, Kinscherf R. Bonaterra GA, et al. Among authors: denkert c. Cancers (Basel). 2022 Sep 22;14(19):4591. doi: 10.3390/cancers14194591. Cancers (Basel). 2022. PMID: 36230513 Free PMC article.
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
Jank P, Leichsenring J, Kolb S, Hoffmann I, Bischoff P, Kunze CA, Dragomir MP, Gleitsmann M, Jesinghaus M, Schmitt WD, Kulbe H, Sers C, Stenzinger A, Sehouli J, Braicu IE, Westhoff C, Horst D, Denkert C, Gröschel S, Taube ET. Jank P, et al. Among authors: denkert c. J Ovarian Res. 2023 Jul 31;16(1):150. doi: 10.1186/s13048-023-01239-6. J Ovarian Res. 2023. PMID: 37525239 Free PMC article.
486 results